Myriad Genetics Market Cap:
2.628B for May 17, 2013Myriad Genetics Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 2.628B |
| May 16, 2013 | 2.644B |
| May 15, 2013 | 2.676B |
| May 14, 2013 | 2.722B |
| May 13, 2013 | 2.643B |
| May 10, 2013 | 2.642B |
| May 9, 2013 | 2.433B |
| May 8, 2013 | 2.445B |
| May 7, 2013 | 2.259B |
| May 6, 2013 | 2.243B |
| May 3, 2013 | 2.229B |
| May 2, 2013 | 2.204B |
| May 1, 2013 | 2.174B |
| April 30, 2013 | 2.223B |
| April 29, 2013 | 2.201B |
| April 26, 2013 | 2.189B |
| April 25, 2013 | 2.210B |
| April 24, 2013 | 2.169B |
| April 23, 2013 | 2.240B |
| April 22, 2013 | 2.257B |
| April 19, 2013 | 2.282B |
| April 18, 2013 | 2.206B |
| April 17, 2013 | 2.219B |
| April 16, 2013 | 2.202B |
| April 15, 2013 | 2.127B |
| April 12, 2013 | 2.083B |
| April 11, 2013 | 2.076B |
| April 10, 2013 | 2.030B |
| April 9, 2013 | 1.955B |
| April 8, 2013 | 1.963B |
| April 5, 2013 | 1.955B |
| April 4, 2013 | 1.952B |
| April 3, 2013 | 1.944B |
| April 2, 2013 | 1.979B |
| April 1, 2013 | 2.005B |
| March 28, 2013 | 2.047B |
| March 27, 2013 | 2.037B |
| March 26, 2013 | 1.998B |
| March 25, 2013 | 2.010B |
| March 22, 2013 | 2.030B |
| March 21, 2013 | 2.054B |
| March 20, 2013 | 2.040B |
| March 19, 2013 | 2.049B |
| March 18, 2013 | 2.056B |
| March 15, 2013 | 2.087B |
| March 14, 2013 | 2.090B |
| March 13, 2013 | 2.083B |
| March 12, 2013 | 1.986B |
| March 11, 2013 | 1.975B |
| March 8, 2013 | 2.025B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
MYGN Market Cap Benchmarks
| Companies | |
|---|---|
| Genomic Health | 1.126B |
| Qiagen | 4.365B |
| Conceptus | 1.006B |
MYGN Market Cap Rankings
| Overall |
82nd percentile 1322 of 7593 |
| Sector |
83rd percentile 110 of 650 in Healthcare |
| Industry |
80th percentile 12 of 61 in Diagnostics & Research |
MYGN Market Cap Range, Past 5 Years
| Minimum | 1.363B | Jul 22 2010 |
| Maximum | 4.106B | Apr 13 2009 |
| Average | 2.242B |
